US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 17.290
  • +0.690+4.16%
Close Oct 1 16:00 ET
  • 17.290
  • 0.0000.00%
Post 16:01 ET
1.56BMarket Cap-6599P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.849M--
--2024/Q3-- / 1.701M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.849M--
--2024/Q3-- / 1.701M--
--2024/Q22.085M / 1.109M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 08:01 ET

  • 10-Q: Quarterly report

    May 8 16:39 ET

  • NewAmsterdam Pharma | 10-K: FY2023 Annual Report

    Feb 28 08:02 ET

  • NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 7, 2023 07:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data